Overview


According to FutureWise analysis, the market for Botulinum toxin is to reach US$ 6,269.1 million in 2022 and is expected to grow at a CAGR of 7.9% over the forecast period of 2023-2031.

The botulinum toxin (Botox) produced by Clostridium botulinum is a neurotoxic protein. Botulism, which causes death if you ingest it, is the same toxin that causes wrinkles, but doctors use it in small doses to treat a variety of health problems, including underarm sweating, cervical dystonia (a neurological disorder that causes severe neck and shoulder muscle contractions), blepharospasm, strabismus, chronic migraines, and overactive bladder. The use of botulinum toxin is widespread in the treatment of aging signs such as frown lines, forehead lines, square jawlines, and crow's feet. It is also expected that the number of manufacturers and users will grow in a variety of economies, further enhancing the market's growth. As a result, the increasing influence of aesthetics among consumers coupled with an increase in manufacturers from various developed and developing countries will further propel Botulinum toxin market growth. A major use of botulinum is in the treatment of strabismus, in addition to being used in the cosmetic industry. Botulinum has been used to treat neurological conditions like spasticity, dystonia, tremor, and others. In addition, recent research has concluded that botulinum is useful for treating autonomic disorders, including hypersecretory disorders and detrusor sphincter dysfunctions. It was the growing demand for botulinum to manage diseases that led to the robust growth of the market. Further, botulinum's growing importance in chemo-denervation and dermal filling has created huge demand among the general public. Additionally, the market grew due to the growing importance of aesthetics and personal appearance among the general population. These factors led to the market's burgeoning growth.
Clinically botulinum is used for the treatment of strabismus and huge demand in cosmetic applications. Growing research activities expanded the scope of botulinum for the treatment of neurological conditions like spasticity, dystonia, tremor, and others. Along with this, recent research activities have concluded that botulinum is also used for autonomic disorders like hypersecretory disorders, detrusor sphincter, and others. The growing demand of botulinum in disease management led to the robust growth of the market. Further, the increasing importance of botulinum in chemo-denervation and dermal filling created huge demand among the general population. Along with this, the growing importance of aesthetics and personal appearance among the general population led to the robust growth of the market. All these factors led to the burgeoning growth of the market.
High spending capacity and huge demand aesthetics among the general population of developed economies fuelled the growth of the global market. Developed economies like North America and Europe account for more 60% of the market share. The US dominated the North America market due to high penetration among the general population and end-user segment. UK, Germany, France, and Italy dominated the European market. The Asia Pacific is the most opportunistic market space for market players due to the limited presence of manufacturers. It represented a fast-growing region during the forecast period. Latin America and Rest of World is a highly untapped market due to the limited presence of manufacturers and less adoption.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Botulinum Toxin Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Botulinum Toxin Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Allergan
  • Merz Pharma
  • Medytox
  • Galderma
  • Lanzhou Institute of Biological Products Co.,Ltd
  • Hugel,Inc
  • Revanance Therapeutics,Inc
  • US WorldMeds,LLC
  • Ipsen group
  • Eisai Co., Ltd
  • Evolus, Inc
  • AbbVie
  • Pfizer Inc

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Botulinum Toxin Market:

July 2022- The long-lasting botulinum toxin Fastox Pharma introduced LAST technology at the "Toxins 2022 International Conference." Fastox found that combining fast-acting myorelaxant medications with botulinum toxin type A (BoNT/A) is expected to hasten the BoNT/commencement A's of action.

The accessibility of various botulinum toxin medications, such as Botox, Xeomin, and Disport, may promote the market's growth. Injections of botulinum toxin are increasingly employed in a variety of aesthetic procedures, including the treatment of glabellar lines, chemical browlifts, and forehead lines, which is predicted to hasten market growth over the forecast period. Additionally, during the past decade, consumers have chosen quick, painless alternatives to invasive cosmetic surgery in order to seem healthy and youthful. The need for aesthetic and less invasive surgery has increased, as a result, spurring the development of botulinum toxin therapy. Moreover, botulinum toxin usage in managing several serious and enduring disorders, such as cervical dystonia, migraines, and spasticity is anticipated to further expand market growth. It is believed that this toxin will have hundreds of potential therapeutic applications, and at the moment, healthcare providers are paying for more than 100 of these applications. Key market players heavily invest in their research and development for product establishment due to the rising therapeutic applications. This is expected to provide enormous prospects for market expansion. However, these drugs have several therapeutic and aesthetic applications their severe side effects are projected to restrain market expansion throughout the botulinum toxin market. Eye dryness or excessive tears, cockeyed eyebrows or droopy eyelids, headache-like symptoms, swelling, soreness, or bruising at the injection site, and headache-like symptoms are all potential botulinum toxin side effects. The high cost of these procedures is a further obstacle impeding the market expansion of botulinum toxin.

By Type

  • Botulinum Toxin A
  • Botulinum Toxin B

By Application

  • Therapeutic
    • Chronic Migraine
    • Spasticity
    • Overactive Bladder
    • Cervical Dystonia
    • Blepharospasm
    • Others
  • Aesthetic

By End-User

  • Specialty and Dermatology Clinics
  • Hospitals and Clinics
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America and Europe registered the highest share in the market in 2022. key factors such as the increased demand for aesthetic surgeries, the incidence of various illnesses, and the expansion of research and development for botulinum toxin's therapeutic uses are anticipated to drive market expansion in this region.

Additionally, APAC will grow at the highest CAGR. Due to favorable reimbursement, a sizable patient base, and advanced medical facilities. Higher levels of beauty consciousness and aesthetic awareness are present in nations like South Korea, China, and Japan, which is anticipated to fuel the industry.


  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Botulinum Toxin Market By Type, By Application, By End-User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- Application launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Botulinum Toxin Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Botulinum Toxin Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Botulinum Toxin Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Botulinum Toxin Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Botulinum Toxin A
        2. Botulinum Toxin B

  • 8.   Botulinum Toxin Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Therapeutic
         1.1. Chronic Migraine
         1.2. Spasticity
         1.3. Overactive Bladder
         1.4. Cervical Dystonia
         1.5. Blepharospasm
         1.6. Others
        2. Aesthetic

  • 9.   Botulinum Toxin Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Specialty and Dermatology Clinics
        2. Hospitals and Clinics
        3. Others

  • 10.   North America Botulinum Toxin Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
                  2.1. U.S.A
          2.2. Canada
          2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Botulinum Toxin Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
                  2.1. Brazil
          2.2. Venezuela
          2.3. Argentina
          2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2017-2022

  • 12.   Europe Botulinum Toxin Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
                  2.1. Germany
           2.2. U.K
           2.3. France
           2.4. Italy
           2.5. Spain
              2.6. Russia
              2.7. Poland
              2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Botulinum Toxin Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
                 2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
                 2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Allergan
         1.1. Company Overview
         1.2. Application Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Merz Pharma
         2.1. Company Overview
         2.2. Application Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Medytox
         3.1. Company Overview
         3.2. Application Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Galderma
         4.1. Company Overview
         4.2. Application Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Lanzhou Institute of Biological Products Co.,Ltd
         5.1. Company Overview
         5.2. Application Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Hugel,Inc
         6.1. Company Overview
         6.2. Application Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Revanance Therapeutics,Inc
         7.1. Company Overview
         7.2. Application Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. US WorldMeds,LLC
         8.1. Company Overview
         8.2. Application Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Ipsen group
         9.1. Company Overview
         9.2. Application Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Eisai Co., Ltd,
         10.1. Company Overview
         10.2. Application Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Evolus, Inc
         11.1. Company Overview
         11.2. Application Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. AbbVie
         12.1. Company Overview
         12.2. Application Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Pfizer Inc
         13.1. Company Overview
         13.2. Application Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients